Cargando…

(5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thia­zolo[2,3-d][1,3,5]benzoxadiazo­cine

The title compound, C(13)H(14)N(2)OS, crystallizes as a racemate in a non-chiral space group. It represents a conformationally restricted analogue of so-called Biginelli compounds known to exhibit multiple pharmacological activities and was selected for a single-crystal X-ray analysis in order to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kettmann, Viktor, Světlík, Jan, Veizerová, Lucia
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971350/
https://www.ncbi.nlm.nih.gov/pubmed/21578538
http://dx.doi.org/10.1107/S1600536809044729
_version_ 1782190606719647744
author Kettmann, Viktor
Světlík, Jan
Veizerová, Lucia
author_facet Kettmann, Viktor
Světlík, Jan
Veizerová, Lucia
author_sort Kettmann, Viktor
collection PubMed
description The title compound, C(13)H(14)N(2)OS, crystallizes as a racemate in a non-chiral space group. It represents a conformationally restricted analogue of so-called Biginelli compounds known to exhibit multiple pharmacological activities and was selected for a single-crystal X-ray analysis in order to probe the chemical and spatial requirements of some kinds of activity. It was found that the state of hybridization of the formally aminic nitro­gen of the heterocycle is between sp (2) and sp (3) with the lone-pair electrons partially delocalized through conjugation with the sulfur atom rather than the double bond of the pyrimidine nucleus. As a result, the thia­zolo ring adopts a flat-envelope conformation and the puckering of the central pyrimidine ring is close to a half-chair. The critical phenyl ring is fixed in a pseudo-axial and perpendicular [dihedral angle 84.6 (1)°] orientation with respect to the pyrimidine ring via an oxygen bridge.
format Text
id pubmed-2971350
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-29713502010-12-30 (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thia­zolo[2,3-d][1,3,5]benzoxadiazo­cine Kettmann, Viktor Světlík, Jan Veizerová, Lucia Acta Crystallogr Sect E Struct Rep Online Organic Papers The title compound, C(13)H(14)N(2)OS, crystallizes as a racemate in a non-chiral space group. It represents a conformationally restricted analogue of so-called Biginelli compounds known to exhibit multiple pharmacological activities and was selected for a single-crystal X-ray analysis in order to probe the chemical and spatial requirements of some kinds of activity. It was found that the state of hybridization of the formally aminic nitro­gen of the heterocycle is between sp (2) and sp (3) with the lone-pair electrons partially delocalized through conjugation with the sulfur atom rather than the double bond of the pyrimidine nucleus. As a result, the thia­zolo ring adopts a flat-envelope conformation and the puckering of the central pyrimidine ring is close to a half-chair. The critical phenyl ring is fixed in a pseudo-axial and perpendicular [dihedral angle 84.6 (1)°] orientation with respect to the pyrimidine ring via an oxygen bridge. International Union of Crystallography 2009-10-31 /pmc/articles/PMC2971350/ /pubmed/21578538 http://dx.doi.org/10.1107/S1600536809044729 Text en © Kettmann et al. 2009 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Kettmann, Viktor
Světlík, Jan
Veizerová, Lucia
(5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thia­zolo[2,3-d][1,3,5]benzoxadiazo­cine
title (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thia­zolo[2,3-d][1,3,5]benzoxadiazo­cine
title_full (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thia­zolo[2,3-d][1,3,5]benzoxadiazo­cine
title_fullStr (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thia­zolo[2,3-d][1,3,5]benzoxadiazo­cine
title_full_unstemmed (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thia­zolo[2,3-d][1,3,5]benzoxadiazo­cine
title_short (5R*,11R*)-5-Methyl-1,2-dihydro-5,11-methano-5H,11H-1,3-thia­zolo[2,3-d][1,3,5]benzoxadiazo­cine
title_sort (5r*,11r*)-5-methyl-1,2-dihydro-5,11-methano-5h,11h-1,3-thia­zolo[2,3-d][1,3,5]benzoxadiazo­cine
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971350/
https://www.ncbi.nlm.nih.gov/pubmed/21578538
http://dx.doi.org/10.1107/S1600536809044729
work_keys_str_mv AT kettmannviktor 5r11r5methyl12dihydro511methano5h11h13thiazolo23d135benzoxadiazocine
AT svetlikjan 5r11r5methyl12dihydro511methano5h11h13thiazolo23d135benzoxadiazocine
AT veizerovalucia 5r11r5methyl12dihydro511methano5h11h13thiazolo23d135benzoxadiazocine